Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Total revenue $ 151 $ 607 $ 168 $ 1,653
Operating expenses:        
Research and development 8,838 2,712 14,890 5,376
General and administrative 2,891 3,021 5,858 5,502
Total operating expenses 11,729 5,733 20,748 10,878
Loss from operations (11,578) (5,126) (20,580) (9,225)
Investment and other income, net 459 7 490 3
Interest expense (30) 0 (64) 0
Net loss $ (11,149) $ (5,119) $ (20,154) $ (9,222)
Net loss per common share attributable to common stockholders basic (in usd per share) $ (0.16) $ (0.43) $ (0.31) $ (0.87)
Net loss per common share attributable to common stockholders diluted (in usd per share) $ (0.16) $ (0.43) $ (0.31) $ (0.87)
Weighted-average shares used to compute net loss per share attributable to common stockholders, basic 68,856,370 11,819,152 64,646,565 10,595,960
Weighted-average shares used to compute net income (loss) per share attributable to common stockholders, diluted 68,856,370 11,819,152 64,646,565 10,595,960
Collaboration revenue        
Total revenue $ 0 $ 607 $ 0 $ 1,653
Royalty revenue        
Total revenue $ 151 $ 0 $ 168 $ 0